LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 46 filers reported holding LYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $133 | -5.0% | 34 | 0.0% | 0.00% | – |
| Q2 2023 | $140 | – | 34 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 34 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 34 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 34 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 34 | -99.6% | 0.00% | – |
| Q1 2022 | $31,000 | +675.0% | 7,759 | +813.9% | 0.00% | – |
| Q4 2021 | $4,000 | – | 849 | +2397.1% | 0.00% | – |
| Q3 2021 | $0 | – | 34 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 34 | -100.0% | 0.00% | – |
| Q1 2021 | $1,709,000 | -21.5% | 147,400 | -22.8% | 0.00% | – |
| Q4 2020 | $2,177,000 | +9795.5% | 191,000 | +9858.3% | 0.00% | – |
| Q3 2020 | $22,000 | -42.1% | 1,918 | -42.9% | 0.00% | – |
| Q2 2020 | $38,000 | – | 3,357 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,777,251 | $3,572,275 | 0.74% |
| Perceptive Advisors | 9,146,730 | $18,384,927 | 0.54% |
| PURA VIDA INVESTMENTS, LLC | 1,996,972 | $4,013,914 | 0.41% |
| VR Adviser, LLC | 924,170 | $1,857,582 | 0.36% |
| Nantahala Capital Management | 2,220,830 | $4,463,868 | 0.34% |
| Ikarian Capital, LLC | 343,685 | $711,427 | 0.16% |
| Soleus Capital Management, L.P. | 592,417 | $1,190,758 | 0.12% |
| Clearline Capital LP | 119,128 | $239,448 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 146,800 | $303,876 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 34,721 | $69,789 | 0.00% |